Immune tolerance induced by H2-Bl plasmid vectors for heterotopic heart transplantation in mice
10.3760/cma.j.issn.1001-4497.2010.05.019
- VernacularTitle:重组pEGFP-N1-H2Bl质粒载体诱导心脏移植免疫耐受
- Author:
Liyuan LI
;
Yijun XU
;
Li CHEN
;
Yongzhi DENG
;
Jie MA
;
Fangfang FU
- Publication Type:Journal Article
- Keywords:
H2-Bl;
Heart transplantation;
Immune tolerance;
Th1/Th2 cytokines;
CD40
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2010;26(5):347-350
- CountryChina
- Language:Chinese
-
Abstract:
Objective Cervical heterotopic heart transplantation model was established in different inbred strains of mice with modified cuff technique. Inbred male Balb/c mice and C57BL/6 mice were selected as donors and recipients, respectively. Mice were randomly assigned into four groups: control group (the donor hearts were perfused through coronary artery with 200 μl, 0℃~4℃ St. Thomas Ⅱ solution during 2 to 3 min, then they were immersed in it for 15 min), CsA group ( the donor hearts were perfused with the same method as for the control's and intraperitoneal injection of CsA 5 mg· g-1 · d -1 was given after surgery ), H2-B1 transfection group (the donor hearts were perfused through coronary artery with 200 μl, 0℃ -4℃ St. Thomas Ⅱ solution contained with 30 μg H2-Bl plasmid vectors during 2 to 3 min, then they were immersed in it for 15 min ), and H2-B1 + CsA group ( the donor hearts were perfused with St. Thomas Ⅱ solution contained H2-Bl gene plasmid and intraperitoneal injection of CsA was given after surgery as mentioned above. ). At 1,3 and 7 days after transplantation, three allografts were harvested at each time points in all of the groups, respectively, for pathological examination and analysis of CD40 expression with immunohistochemistry assays. The expression of Th1/Th2 cytokines were also determined with flow cytometry. The survival time of rest allografts were observed. Results Histological features for rejection were observed more apparent in the grafts of control group than those in other groups, especially those in H2-Bl + CsA group. The expression of CD40 in H2-Bl + CsA group and CsA group was lower significantly than that of the control group ( P <0.01 ), so was the expression of CD40 in the H2-Bl group as compare with that of the control group (P <0.05). No significant difference between H2-Bl group and CsA group (P >0.05 ) at 7 days was observed. The expression of IL-2, TNF-α (Th1 cytokines) in control group was much higher than that in other groups, and the expression of IL-4 ( Th2 cytokine) in control group was much lower ( P <0.05 ). The level of IL-4 in CsA group increased significantly at 3 days ( P < 0.05 ), with a peak level at 7 days after transplantation (P<0.01). The survival time of grafts was significantly prolonged in CsA group (P<0.01), H2-Bl group (P<0.05) and H2-Bl+CsA group(P<0.01). Conclusion Treating the donor hearts with H2-Bl plasmid vectors at the time of transplantation may suppress rejection in the heart allografts and prolong the survival time through some presumed mechanisms such as preventing upregulation of CD40 expression, relucing the production of IL-2 and TNF-α, increasing the production of IL-4, and as a result, inducing immune tolerance, as well as improving the function of transplanted heart grafts.